Mitochondrial Medicine 2021 Virtual

Meet the Scientific Program Faculty

May 7 and May 21 - Noon to 2:00pm EDT

June 4 and June 18 - Noon to 2:00pm EDT

Click Here for the June 24 CME Activity

Bruce Cohen, MD
2021 Course Chair
Akron Children's Hospital
Akron, OH
Bill Copeland, PhD
2021 Course Chair
National Institute of Environmental Health Sciences, Durham, DC

Friday, May 7, 2021 - 12:00 PM to 1:30 PM EDT

Mitochondria and Metabolism Platform

Dave Pagliarini, PhD
Washington University School of Medicine, St. Louis, MO

Mitochondrial Systems Biochemistry

Heather Christofk, PhD
University of California Los Angeles
Los Angeles, CA

Targeting Cancer Asparagine Dependence

Joshua Rabinowitz, MD, PhD
Princeton University
Princeton, NJ

TCA Cycle Fuels and Fluxes

Poster Abstract Presentations - May 7 - 1:30pm EDT

Abstract Presentations with Live Q&A

  • Synthetic Messenger RNA Rescues Very Long-Chain Acyl-CoA Dehydrogenase Deficiency in Fibroblasts from Patients and a Murine Model, Xuejun Zhao
  • Maladaptive Nutrient Signaling Sustains the m.3243A>G mtDNA Mutation, Chih-Yao Chung
  • The gnomAD Database of Mitochondrial DNA Variation from 56,434 Individuals, Sarah Calvo

Friday, May 21, 2021 - 12:00 PM to 1:30 PM EDT

Mitochondria and Metabolism Platform

Eric Schon, PhD
Columbia University
New York, NY

Mitochondria in Alzheimer Disease: It's Not What You Think

Jared Rutter, PhD
University of Utah
Salt Lake City, UT

Mitochondria, Metabolism and Cellular Decisions

Anu Suomalainen, MD, PhD
University of Helsinki
Helsinki, Finland

Mitochondria and Metabolism - Topic TBD

Poster Abstract Presentations - May 21 - 1:30pm EDT

Abstract Presentations with Live Q&A

  • A Cardiolipin-Binding Peptide Improves Cellular Bioenergetics in Mitochondrial Trifunctional Protein (TFP)-Deficient Mice and Patient Fibroblasts, Meicheng Wang
  • Mitochondrial Protein Import Clogging as a Mechanism of Disease, Liam Coyne
  • SLC25A46 Organizes a Platform for Mitochondrial Membrane Dynamics and Lipid Remodeling, Jana Schuettpelz

Friday, June 4, 2021 - 12:00 PM to 1:30 PM EDT

Gene Editing/Gene Therapy Platform

Carlos Moraes, PhD
University of Miami
Miami, FL

Progress on Gene Therapy for mtDNA Diseases

Steven Gray, PhD
University of Texas Southwestern Medical Center, Dallas, TX

Gene Therapy for SURF1-related Leigh Syndrome

Mickael Decressac, PhD
Grenoble Institute of Neuroscience (GIN), France

Towards Gene Therapy for Leigh Syndrome

Poster Abstract Presentations - June 4 - 1:30pm EDT

Abstract Presentations with Live Q&A

  • Modulation of the Nuclear Epigenome as a New Strategy for Mitochondrial DNA Heteroplasmy Shift, Lia Mayorga
  • Assessment of Lenadogene Nolparvovec (rAAV2/2-ND4) Gene Therapy Efficacy in Leber Hereditary Optic Neuropathy Using an External Control Group, Mark Moster
  • Gene Replacement Therapy for SURF1-Related Leigh Syndrome Using AAV9, Qinglan Ling

Friday, June 18, 2021 - 12:00 PM to 1:30 PM EDT

Mitochondria in Stress Platform

Jodi Nunnari, PhD
University of California Davis
Davis, CA

Mitochondrial Behavior

Vamsi Mootha, MD
Harvard Medical School
Boston, MA

Hypoxia as a Therapy for Mitochondrial Disease

Phillip West, PhD
Texas A&M University College of Medicine, Bryan, TX

Mitochondrial Control of Innate Immunity and Inflammation

Poster Abstract Presentations - June 18 - 1:30pm

Abstract Presentations with Live Q&A

  • Characterization of Two Variants in the Mitochondrial Topoisomerase Gene TOP1MT Reveal a Potential Involvement in Human Pathology, Iman Al Khatib
  • Identification of Novel Compounds to Treat Rare Mitochondrial Diseases, Arwen Gao
  • COVID-19 Topic - TBD